Back To Schedule
Thursday, June 18 • 5:00pm - 6:00pm
#555 OD: ON DEMAND - Updates of Drug Evaluation and Inspection in China

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Forum
Level: Intermediate

This forum will include discussions and updates from CCDIE and NMPA leadership on many important topics including the implementation of the revision of drug law and updated regulations, ICH implementation, and advanced therapy.

Learning Objectives

Discuss updates from CCDIE and NMPA leadership.


Ling Su, PhD


New Progress of New Drug Evaluation
Fan Zhang, MS

Pre-Approval Inspection in China: Its Evolution and Key Points of Evaluation Principles
Yi Cao, MS

Pre-Approval Inspection in China: Its Evolution and Key Points of Evaluation Principles
Tiewei Zhai

avatar for Ling Su

Ling Su

Professor, Shenyang Pharmaceutical University
Ling Su, PhD, is Professor in Shenyang Pharmaceutical University, and a Venture Partner with Lilly Asia Ventures. Dr. Su has over 25 years of experience in drug regulatory and development. He had worked in the Chinese regulatory agency and US FDA, as well as in various R&D management... Read More →
avatar for Yi Cao

Yi Cao

Deputy Division Director, Div 4, Center for Food and Drug Inspection (CFDI), National Medical Products Administration (NMPA)
Mr. Cao is mainly responsible for pre-approval inspection and overseas GMP inspection. Before joined in CFDI, he worked at Beijing Institute for Drug Control for 5 years

Tiewei Zhai

Deputy Division Director, Inspection Division 4, Center for Food and Drug Inspec, National Medical Products Administration (NMPA)
avatar for Fan Zhang

Fan Zhang

Project Manager, Center for Drug Evaluation (CDE), National Medical Products Administration (NMPA)
Ms. Zhang graduated from Long Island University and holds Master degree of Pharmacology and toxicology.

Thursday June 18, 2020 5:00pm - 6:00pm EDT
TBD Virtual Event Horsham, PA 19044
  09: Regulatory, Forum